MedTrace Logo

Screening of Patients Admitted to a Local Hospital With Pocket-sized Ultrasound

NCT01081210 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2021-11-09

No results posted yet for this study

Summary

Ultrasound (US) is widely used as a diagnostic tool in a hospital setting. In a medical department, diagnosis like heart failure or most kinds of heart diseases, hypervolemia, hypovolemia, pleural effusion, pericardial effusion, ascites, diseases in the gall bladder/bile tract, urine tract and venous thrombosis are common. US is the key diagnostic tool in these diagnosis, and on early diagnosis is crucial both on behalf of the patients well-being, and for hospital logistic reasons.

1. The aim is to study the clinical use of pocket sized US as a screening diagnostic tool in an department of internal medicine.

Method: All patients admitted (in certain preset periods) to Department of medicine will be screened with pocket sized US by expert user. Changes in diagnoses, as well as medications as a result of US screening will be the endpoints. US findings will be validated against standard echocardiography, or standard US/CT/MRI performed at the Radiological department.
2. The aim is to study the clinical use of pocket sized US as a screening diagnostic tool in a department of cardiology.

Method: All patients admitted (in certain preset periods) to Department of cardiology will be screened with pocket sized US for heart disease, pericardial and pleural effusion. Examinations by expert users. Specific findings could be myocardial dysfunction as heart failure, cardiomyopathies, regional dysfunction due to ischemia, valvular dysfunction, atrial enlargement, and pleural/pericardial effusion. Changes in diagnoses, as well as medications as a result of US screening will be the endpoints. US findings will be validated against standard echocardiography in all.
3. As in 1), but examination by non-expert users compared to expert users.

Conditions

Interventions

OTHER

Ultrasound examination

Screening with bedside ultrasound examination

Sponsors & Collaborators

  • Norwegian University of Science and Technology

    collaborator OTHER

  • Helse Nord-Trøndelag HF

    lead OTHER

Principal Investigators

  • Havard Dalen, MD · Nord-Trøndelag Health Trust

Eligibility

Min Age
16 Years
Max Age
110 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2010-09-30
Completion
2010-10-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01081210 on ClinicalTrials.gov